Literature DB >> 18628418

Successful coordination and execution of nontherapeutic studies in a cooperative group setting: lessons learned from Children's Oncology Group studies.

Andrea Carter1, Wendy Landier, Amy Schad, Allison Moser, Alexandra Schaible, Cara Hanby, Seira Kurian, F Lennie Wong, Doojduen Villaluna, Smita Bhatia.   

Abstract

The immense progress made in childhood cancer survival has been due to the systematic and efficient conduct of large multicenter therapeutic trials, using the infrastructure developed by national cooperative groups. These therapeutic trials have been successful, in part due to the high participation rates by the participating member institutions. However, participation in nontherapeutic trials in the cooperative group setting has lagged behind that of therapeutic trials for a variety of reasons, such as lack of institutional resources, leading to low priority given to such activities. The purpose of this report is to share some of the methods developed and successfully implemented by a coordinating center (City of Hope National Medical Center) to maximize institutional participation and patient enrollment and to standardize data collection and quality control, in order to ensure the successful execution of two large, extramurally funded, cooperative group nontherapeutic studies. To date, over 175 institutions have obtained regulatory approval for the protocols showcased here, accrual has been on target, and completeness and quality of the collected data have been excellent. The successful execution of these nontherapeutic studies shows the advantages of diverse study publicity techniques, detailed standardized operating procedures, and effective utilization of technological resources.

Entities:  

Mesh:

Year:  2008        PMID: 18628418      PMCID: PMC2590654          DOI: 10.1158/1055-9965.EPI-07-2862

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  26 in total

1.  Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.

Authors:  Smita Bhatia; Harland N Sather; Olga B Pabustan; Michael E Trigg; Paul S Gaynon; Leslie L Robison
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

2.  Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.

Authors:  L C Kremer; E C van Dalen; M Offringa; J Ottenkamp; P A Voûte
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

3.  Stature loss following treatment for Wilms tumor.

Authors:  C J Hogeboom; S C Grosser; K A Guthrie; P R Thomas; G J D'Angio; N E Breslow
Journal:  Med Pediatr Oncol       Date:  2001-02

4.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

5.  Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.

Authors:  D M Green; Y A Grigoriev; B Nan; J R Takashima; P A Norkool; G J D'Angio; N E Breslow
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

6.  Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.

Authors:  Smita Bhatia; Harland N Sather; Nyla A Heerema; Michael E Trigg; Paul S Gaynon; Leslie L Robison
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

Review 7.  Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review.

Authors:  L C M Kremer; E C van Dalen; M Offringa; P A Voûte
Journal:  Ann Oncol       Date:  2002-04       Impact factor: 32.976

8.  Breast cancer and other second neoplasms after childhood Hodgkin's disease.

Authors:  S Bhatia; L L Robison; O Oberlin; M Greenberg; G Bunin; F Fossati-Bellani; A T Meadows
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

9.  Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.

Authors:  J P Neglia; D L Friedman; Y Yasui; A C Mertens; S Hammond; M Stovall; S S Donaldson; A T Meadows; L L Robison
Journal:  J Natl Cancer Inst       Date:  2001-04-18       Impact factor: 11.816

10.  Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study.

Authors:  Charles A Sklar; Ann C Mertens; Pauline Mitby; Glenn Occhiogrosso; Jing Qin; Glenn Heller; Yutaka Yasui; Leslie L Robison
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 6.134

View more
  8 in total

1.  Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma.

Authors:  Idriss M Bennani-Baiti; Aaron Cooper; Elizabeth R Lawlor; Maximilian Kauer; Jozef Ban; Dave N T Aryee; Heinrich Kovar
Journal:  Clin Cancer Res       Date:  2010-06-04       Impact factor: 12.531

2.  Rapid autopsy of a patient with recurrent anaplastic ependymoma.

Authors:  Katharine Rae Lange; Cheryl Fischer; Prajwal Rajappa; Scott Connors; David Pisapia; Jeffrey P Greenfield; Himisha Beltran; Mark Rubin; Juan Miguel Mosquera; Yasmin Khakoo
Journal:  Palliat Support Care       Date:  2017-09-25

3.  Strategies to improve success of pediatric cancer cooperative group quality of life studies: a report from the Children's Oncology Group.

Authors:  Puja G Whitlow; Mae Caparas; Patricia Cullen; Christine Trask; Fiona Schulte; Leanne Embry; Rajaram Nagarajan; Donna L Johnston; Lillian Sung
Journal:  Qual Life Res       Date:  2014-11-29       Impact factor: 4.147

4.  Leveraging Clinical Trial Populations and Data from the Children's Oncology Group for Cancer Survivorship Research.

Authors:  Eric J Chow; Lena E Winestone; Philip J Lupo; Lisa R Diller; Tara O Henderson; Nina S Kadan-Lottick; Jennifer M Levine; Kirsten K Ness; Smita Bhatia; Saro H Armenian
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-09-02       Impact factor: 4.090

5.  Accrual in supportive care trials in pediatric oncology, a challenge!

Authors:  R A Schoot; C H van Ommen; H N Caron; W J E Tissing; M D van de Wetering
Journal:  Support Care Cancer       Date:  2012-04-04       Impact factor: 3.603

6.  Facilitating accrual to cancer control and supportive care trials: the clinical research associate perspective.

Authors:  David Vanhoff; Tanya Hesser; Katherine Patterson Kelly; David Freyer; Susan Stork; Lillian Sung
Journal:  BMC Med Res Methodol       Date:  2013-12-31       Impact factor: 4.615

7.  Patient-Reported Outcome Coordinator Did Not Improve Quality of Life Assessment Response Rates: A Report from the Children's Oncology Group.

Authors:  Donna Johnston; Robert Gerbing; Todd Alonzo; Richard Aplenc; Rajaram Nagarajan; Fiona Schulte; Patricia Cullen; Lillian Sung
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

8.  Reasons for non-completion of health related quality of life evaluations in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Authors:  Donna L Johnston; Rajaram Nagarajan; Mae Caparas; Fiona Schulte; Patricia Cullen; Richard Aplenc; Lillian Sung
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.